| Mr Seyun Kim, MD | |
|
1501 16th St Apt 205, Sacramento, CA 95814-6075 | |
| (916) 812-1062 | |
| Not Available |
| Full Name | Mr Seyun Kim |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 13 Years |
| Location | 1501 16th St Apt 205, Sacramento, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508197591 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 28650 (Nebraska) | Secondary |
| 207P00000X | Emergency Medicine | 57508 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jewish Hospital & St Mary's Healthcare | Louisville, KY | Hospital |
| Ascension Good Samaritan Hospital | Merrill, WI | Hospital |
| Ascension St Michaels Hospital | Stevens point, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aspirus Merrill Hospital And Clinics Inc | 0143117556 | 25 |
| Southeastern Emergency Physicians Llc | 2466364997 | 491 |
News Archive
Protalix BioTherapeutics, Inc.,a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell based expression system, today announced that the Company's common stock has been approved for listing on the Tel Aviv Stock Exchange in addition to its current listing on the NYSE Amex.
The latest report from the Australian Institute of Health and Welfare reveals that heart disease and heart attacks are still the most common causes of death.
Customers at chain restaurants throughout the United States will start to see more menus that list calorie counts for different food options on the list, but will this motivate people to order healthier items?
It is known that teeth can protect themselves, to some extent, from attack by bacteria but that inflammation within a tooth can be damaging and, in extreme cases, lead to abscess or death of the tooth. New research published in BioMed Central's open access journal BMC Immunology shows that odontoblast cells are part of the immune system and fight to protect teeth from decay.
› Verified 6 days ago
| Entity Name | Aspirus Rhinelander & Tomahawk Hospitals & Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144991340 PECOS PAC ID: 9335059856 Enrollment ID: O20031126000706 |
News Archive
Protalix BioTherapeutics, Inc.,a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell based expression system, today announced that the Company's common stock has been approved for listing on the Tel Aviv Stock Exchange in addition to its current listing on the NYSE Amex.
The latest report from the Australian Institute of Health and Welfare reveals that heart disease and heart attacks are still the most common causes of death.
Customers at chain restaurants throughout the United States will start to see more menus that list calorie counts for different food options on the list, but will this motivate people to order healthier items?
It is known that teeth can protect themselves, to some extent, from attack by bacteria but that inflammation within a tooth can be damaging and, in extreme cases, lead to abscess or death of the tooth. New research published in BioMed Central's open access journal BMC Immunology shows that odontoblast cells are part of the immune system and fight to protect teeth from decay.
› Verified 6 days ago
| Entity Name | Divine Savior Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124083894 PECOS PAC ID: 5799684007 Enrollment ID: O20040225000909 |
News Archive
Protalix BioTherapeutics, Inc.,a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell based expression system, today announced that the Company's common stock has been approved for listing on the Tel Aviv Stock Exchange in addition to its current listing on the NYSE Amex.
The latest report from the Australian Institute of Health and Welfare reveals that heart disease and heart attacks are still the most common causes of death.
Customers at chain restaurants throughout the United States will start to see more menus that list calorie counts for different food options on the list, but will this motivate people to order healthier items?
It is known that teeth can protect themselves, to some extent, from attack by bacteria but that inflammation within a tooth can be damaging and, in extreme cases, lead to abscess or death of the tooth. New research published in BioMed Central's open access journal BMC Immunology shows that odontoblast cells are part of the immune system and fight to protect teeth from decay.
› Verified 6 days ago
| Entity Name | Aspirus Merrill Hospital & Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124084678 PECOS PAC ID: 0143117556 Enrollment ID: O20040301001179 |
News Archive
Protalix BioTherapeutics, Inc.,a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell based expression system, today announced that the Company's common stock has been approved for listing on the Tel Aviv Stock Exchange in addition to its current listing on the NYSE Amex.
The latest report from the Australian Institute of Health and Welfare reveals that heart disease and heart attacks are still the most common causes of death.
Customers at chain restaurants throughout the United States will start to see more menus that list calorie counts for different food options on the list, but will this motivate people to order healthier items?
It is known that teeth can protect themselves, to some extent, from attack by bacteria but that inflammation within a tooth can be damaging and, in extreme cases, lead to abscess or death of the tooth. New research published in BioMed Central's open access journal BMC Immunology shows that odontoblast cells are part of the immune system and fight to protect teeth from decay.
› Verified 6 days ago
| Entity Name | Howard Young Medical Center Inc Of Woodruff Wisconsin |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184673352 PECOS PAC ID: 4183519606 Enrollment ID: O20040419000970 |
News Archive
Protalix BioTherapeutics, Inc.,a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell based expression system, today announced that the Company's common stock has been approved for listing on the Tel Aviv Stock Exchange in addition to its current listing on the NYSE Amex.
The latest report from the Australian Institute of Health and Welfare reveals that heart disease and heart attacks are still the most common causes of death.
Customers at chain restaurants throughout the United States will start to see more menus that list calorie counts for different food options on the list, but will this motivate people to order healthier items?
It is known that teeth can protect themselves, to some extent, from attack by bacteria but that inflammation within a tooth can be damaging and, in extreme cases, lead to abscess or death of the tooth. New research published in BioMed Central's open access journal BMC Immunology shows that odontoblast cells are part of the immune system and fight to protect teeth from decay.
› Verified 6 days ago
| Entity Name | Aspirus Eagle River Hospital & Clinics, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346204385 PECOS PAC ID: 1658361951 Enrollment ID: O20040518000233 |
News Archive
Protalix BioTherapeutics, Inc.,a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell based expression system, today announced that the Company's common stock has been approved for listing on the Tel Aviv Stock Exchange in addition to its current listing on the NYSE Amex.
The latest report from the Australian Institute of Health and Welfare reveals that heart disease and heart attacks are still the most common causes of death.
Customers at chain restaurants throughout the United States will start to see more menus that list calorie counts for different food options on the list, but will this motivate people to order healthier items?
It is known that teeth can protect themselves, to some extent, from attack by bacteria but that inflammation within a tooth can be damaging and, in extreme cases, lead to abscess or death of the tooth. New research published in BioMed Central's open access journal BMC Immunology shows that odontoblast cells are part of the immune system and fight to protect teeth from decay.
› Verified 6 days ago
| Entity Name | Aspirus Stevens Point Hospital & Clinics, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538112230 PECOS PAC ID: 1850358938 Enrollment ID: O20041210000558 |
News Archive
Protalix BioTherapeutics, Inc.,a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell based expression system, today announced that the Company's common stock has been approved for listing on the Tel Aviv Stock Exchange in addition to its current listing on the NYSE Amex.
The latest report from the Australian Institute of Health and Welfare reveals that heart disease and heart attacks are still the most common causes of death.
Customers at chain restaurants throughout the United States will start to see more menus that list calorie counts for different food options on the list, but will this motivate people to order healthier items?
It is known that teeth can protect themselves, to some extent, from attack by bacteria but that inflammation within a tooth can be damaging and, in extreme cases, lead to abscess or death of the tooth. New research published in BioMed Central's open access journal BMC Immunology shows that odontoblast cells are part of the immune system and fight to protect teeth from decay.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Seyun Kim, MD 1501 16th St Apt 205, Sacramento, CA 95814-6075 Ph: (916) 812-1062 | Mr Seyun Kim, MD 1501 16th St Apt 205, Sacramento, CA 95814-6075 Ph: (916) 812-1062 |
News Archive
Protalix BioTherapeutics, Inc.,a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell based expression system, today announced that the Company's common stock has been approved for listing on the Tel Aviv Stock Exchange in addition to its current listing on the NYSE Amex.
The latest report from the Australian Institute of Health and Welfare reveals that heart disease and heart attacks are still the most common causes of death.
Customers at chain restaurants throughout the United States will start to see more menus that list calorie counts for different food options on the list, but will this motivate people to order healthier items?
It is known that teeth can protect themselves, to some extent, from attack by bacteria but that inflammation within a tooth can be damaging and, in extreme cases, lead to abscess or death of the tooth. New research published in BioMed Central's open access journal BMC Immunology shows that odontoblast cells are part of the immune system and fight to protect teeth from decay.
› Verified 6 days ago
Elizabeth Johnson, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2315 Stockton Blvd, Sacramento, CA 95817 Phone: 916-734-8570 | |
Timothy Sturgill, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 7500 Hospital Dr, Sacramento, CA 95823 Phone: 330-493-4443 | |
Jon Haynes, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2315 Stockton Blvd, Sacramento, CA 95817 Phone: 916-734-8570 Fax: 916-734-7950 | |
Mark Portman, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2315 Stockton Blvd., Sacramento, CA 95817 Phone: 916-734-8570 Fax: 916-734-7950 | |
Juliette Gerardo, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2315 Stockton Blvd, Sacramento, CA 95817 Phone: 916-734-2011 | |
Dr. John Ray Richards, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2315 Stockton Blvd, Pssb 2100 Emergency Medicine, Sacramento, CA 95817 Phone: 916-734-1537 Fax: 916-734-7950 | |
Kerilee Wenker, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2801 L St, Sacramento, CA 95816 Phone: 916-454-2222 |